Company Filing History:
Years Active: 2011
Title: Iain A Sharp: Innovator in Neuronal Transport Inhibition
Introduction
Iain A Sharp is a notable inventor based in Taringa, Australia. He has made significant contributions to the field of neuroscience through his innovative work on conotoxin peptides. His research focuses on the inhibition of neuronal amine transporters, which has important implications for medical treatments.
Latest Patents
Iain A Sharp holds a patent for "Conotoxin peptides useful as inhibitors of neuronal amine transporters." This invention relates to an isolated, synthetic, or recombinant χ-conotoxin peptide that has the ability to inhibit a neuronal amine transporter. The patent also includes nucleic acid molecules encoding all or part of such peptides, antibodies to these peptides, and various uses and methods of treatment involving them.
Career Highlights
Throughout his career, Iain has been associated with Xenome Limited, a company that focuses on developing novel therapeutics based on conotoxin peptides. His work has contributed to advancing the understanding of neuronal transport mechanisms and their potential therapeutic applications.
Collaborations
Iain A Sharp has collaborated with notable colleagues such as Richard James Lewis and Paul Francis Alewood. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Iain A Sharp's contributions to the field of neuroscience through his patent on conotoxin peptides highlight his role as an innovator. His work continues to pave the way for advancements in medical treatments targeting neuronal transporters.